Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

InCarda Therapeutics
150 Post Street, Suite 650
San Francisco, CA 94108
Phone: 650-798-5000
www.incardatherapeutics.com

InCarda Therapeutics is focused on transforming cardiovascular disease treatment through pulmonary delivery of established drugs. The company is product-focused with significant capabilities and led by a team with extensive experience in drug development. The lead product under development is an inhaled therapy intended to treat paroxysmal atrial fibrillation (PAF). InCarda is also working on additional research concepts that leverage the same platform technology to target the heart for acute cardiac conditions. Our approach is designed to reduce the risk normally associated with drug development. Our model is based on the following three tenets: known diseases, known drugs, new delivery.

Key Contact
Name
Grace E. Colon
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
04/28/15 $5,000,000 Series A Morningside Technology Advisory
undisclosed
10/23/20 $30,000,000 Series C Deerfield Management Company, L.P.
HealthCap
Innoviva
undisclosed


Featured Reading